ReviewCancer immunology, immunotherapy : CII2022
PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression.
A Filippone et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this papercites it